基质和含有素的抑制剂与细菌和人类蛋白酶的相互作用
Fatema Amatur Rahman1, Imin Wushur1, Ida Kristine Østnes Hansen2
1Pharmacology and Toxicology Research Group, Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
PloS one
|August 1, 2025
概括
开发针对细菌耐药性的新型抑制剂至关重要. 这项研究使用分子动力学和抑制研究研究了细菌和人类金属蛋白酶 (MPs),揭示了S1.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 细菌耐药性需要新的治疗策略,例如针对细菌毒性因素.
- 细菌金属蛋白酶 (MPs) 是关键的毒性因素,与人类的MPs具有结构相似之处.
- 了解细菌和人类MPs的结合相互作用对于开发选择性抑制剂至关重要.
研究的目的:
- 为了研究细菌MP的热聚素 (TLN) 与模型基质的分子相互作用和裂变模式.
- 评估含有素的化合物对细菌 (TLN,PLN,ALN) 和人类 (MMP-9,MMP-14) MPs 的抑制潜力.
- 阐明细菌和人类MPs之间的抑制剂选择性的结构决定因素.
主要方法:
- 矩阵辅助激光吸附离子化飞行时间质谱 (MALDI-TOF MS) 用于分析基质裂变.
- 分子动力学 (MD) 模拟用于模拟酶基质相互作用.
- 酶抑制动力学研究和诱导适合对接,以评估化合物的疗效和结合方式.
主要成果:
- MALDI-TOF MS通过TLN在基板上确定了三个裂变点,其中Ala-Phe和Gly-Phe之间的偏好裂变点.
- MD模拟与观察到的裂变模式相关联的基质-酶相互作用,突出显示了S1'子口袋的作用.
- 化合物H-1显示出对人类MMPs的选择性,而不是细菌MPs,这是由于细菌S1'亚囊中的硬质障碍.
- 化合物H-2表现出对细菌和人类MPs的抑制活性,具有明显的结合相互作用.
结论:
- S1'亚囊的大小显著影响了细菌和人类MP之间的抑制剂选择性.
- 含氨酸的化合物显示出作为抑制剂的潜力,其结构修饰指导了选择性.
- 对选择性MP抑制的进一步研究可以有助于对抗细菌耐药性和非目标效应.
相关概念视频
Enzyme Inhibition
79.6K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
79.6K
Enzymes
82.7K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
82.7K
Protein Kinases and Phosphatases
13.4K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.4K
Introduction to Mechanisms of Enzyme Catalysis
8.8K
For many years, scientists thought that enzyme-substrate binding took place in a simple "lock-and-key" fashion. This model stated that the enzyme and substrate fit together perfectly in one instantaneous step. However, current research supports a more refined view scientists call induced fit. The induced-fit model expands upon the lock-and-key model by describing a more dynamic interaction between enzyme and substrate. As the enzyme and substrate come together, their interaction causes...
8.8K
Protein-protein Interfaces
13.3K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
13.3K
Factors Affecting Protein-Drug Binding: Drug Interactions
280
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
280


